The Veterinary Neurodegenerative Disease Diagnostics Market is growing as awareness increases about neurological disorders affecting companion and livestock animals. Conditions such as canine cognitive dysfunction, equine neurodegenerative diseases, feline dementia, and prion-related disorders are receiving more clinical attention due to rising pet ownership and the expanding animal healthcare industry. Advances in veterinary neurology, including imaging diagnostics, biomarker testing, genetic analysis, and advanced screening techniques, are driving market adoption. Veterinarians are increasingly utilizing MRI, CT scans, cerebrospinal fluid analysis, and molecular tests to diagnose complex neurological conditions earlier and more accurately. The shift toward preventive care and early disease detection is further boosting demand for diagnostic solutions. Growing investments in veterinary research, improved access to specialty care clinics, and rising expenditure on pet healthcare contribute significantly to market growth. Additionally, increasing awareness among pet owners about age-related cognitive diseases is prompting higher diagnostic testing rates. As veterinary medicine continues to evolve and neurological conditions become more widely recognized, the market for neurodegenerative